WST: westpharma.com Company Total Debt Obligations

Corporate company logo of West Pharma (WST)

West Pharmaceutical Services (WST) production is highly robotized, utilizing AI systems within sterile zones. Debt capital reflects a leverage trend where the indicator level stands at 0.32. Its monopoly status in packaging and FDA certifications create a powerful moat. Business resilience is driven by inelastic demand for injectable components, rendering the company independent of economic crises.

WST West Pharmaceutical Services Inc: Company Aggregate Debts in the range 07/04/2022 - 10/30/2026

West Pharmaceutical Services, Inc. (WST) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price West Pharma Corp|WST - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization West Pharmaceutical Services Inc|WST - Enterprise Value
- company book value details:
Accounting Value per Share West Pharmaceutical Services|WST - Book Capitalization|Market Capitalization to Book Value Ratio westpharma.com|WST - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity West Pharmaceutical Services|WST - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital West Pharma|WST - Company Aggregate Debts|Debts to Net Assets West Pharmaceutical Services Inc|WST - Company Long-Term Debt|Company Short-Term Indebtedness West Pharmaceutical Services|Interim Coverage Ratio westpharma.com
- business earnings and investment ratios data:
WST - Net Income
General company analysis:WST, West Pharma Corp
Product sample of West Pharma

The solvency of West Pharmaceutical Services (WST) is determined by the total volume of borrowed capital, reflecting the market valuation of the issuer's credit risks. By analyzing financial debt levels on the GURU.Markets platform, investors can see the market consensus regarding the company's total liabilities. This metric measures the balance between debt service costs and the efficiency of financial leverage. For West Pharmaceutical Services (WST), stable debt facilitates the modernization of robotic lines that eliminate human error in the production of sterile systems. Optimizing this indicator minimizes the probability of default while preserving capital for technological development.

Competitors of West Pharmaceutical Services

Intuitive Corp - Company Aggregate Debt|Company Aggregate Debts DHR (Danaher Corp.)|Company Total Debt Obligations bd.com (BDX)|STERIS - Company Aggregate Debts|Baxter International Inc. (BAX) - Company Total Debt|MASI: Company Aggregate Debts|Stevanato Group Corp (STVN) - Company Aggregate Debts|Company Debts Teleflex Incorporated|Company Debts MMSI|Company Total Debt NVST (Envista)|ICUI (ICU Medical Inc) - Aggregate Debt Obligations|Company Aggregate Debts XRAY (Dentsply)|Company Total Debt Obligations LeMaitre Corp (LMAT)|ATRC - Company Debts|STAA (staar.com) - Company Aggregate Debt|Niagen (NAGE) - Company Debts|ZIMV - Company Total Debt Obligations|Company Total Debt ANGO|CERS (Cerus Inc) - Company Cumulative Indebtedness|Company Debts Alpha Teknova, Inc. (TKNO)|MGRM (monogramorthopedics.com) - Aggregate Debt Obligations|Sharps Technology - Company Total Debt|Company Aggregate Debts InfuSystem INFU|UTMD - Company Debts|KORU Medical Systems (KRMD) - Company Total Debt|NYXH: Company Aggregate Debts|Company Cumulative Debt microbotmedical.com (MBOT)|Company Debts Pro-Dex|Company Aggregate Debt ZTEK (Zentek Ltd)|Company Total Debt ELUT (Elutia Corp)|Company Cumulative Indebtedness MLSS|Company Debts NEXGEL, Inc. NXGL|Company Total Debt Obligations Retractable Technologies Inc. (RVP)|HBIO: Company Total Debt|Femasys Inc (FEMY) - Company Total Debt|MHUA: Company Aggregate Debts|Company Cumulative Debt Predictive Oncology Inc. (POAI)|Company Debts Callan JMB Inc.|atrioncorp.com (ATRI) - Company Total Debt Obligations|Company Total Debt NURO (NeuroMetrix)